Global expansion Zambon operates across Europe, America and Asia with manufacturing facilities in multiple countries and a growing product pipeline including treatments for Parkinson’s Disease, Cystic Fibrosis, BOS and NCFB, signaling ongoing geographic and therapeutic growth opportunities for partnerships, distribution, and supply agreements.

Pipeline and partnerships The company is actively expanding its global pipeline and collaborates with external partners through Zcube and strategic alliances (for example with Amneal) to advance Parkinson’s and other high-need indications, presenting opportunities for co-development, licensing, and commercialization deals.

Integrated supply End-to-end production control via Zach-Zambon Chemicals and a focus on full production chain management offers potential for API sourcing, custom synthesis, and scalable manufacturing partnerships to strengthen supply reliability and cost efficiency.

Digital and analytics Adoption of technologies such as Kinaxis for supply chain orchestration and Power BI for analytics indicates openness to digital transformation, creating opportunities to propose advanced planning, demand forecasting, and data-driven optimization services.

Open innovation Active venture capital and accelerator programs through Zcube Open Accelerator, plus a home care and patient support ecosystem, suggest avenues for selling digital health solutions, patient engagement platforms, and service-based offerings aligned with value-based care.